Medrad launches PET infusion system
Medrad has launched its next generation Intego PET Infusion System.
The Intego PET Infusion System remains the only FDA-cleared device for automated, controlled infusion of F18-FDG and F18-NaF. The new system is smaller, more power-driven and features enhancements to technologist workflow, according to the Warrendale, Pa.-based business unit of Bayer HealthCare.
The Intego will be on display at the annual meeting of the Society of Nuclear Medicine (SNM), June 4-8, in San Antonio.
The Intego PET Infusion System remains the only FDA-cleared device for automated, controlled infusion of F18-FDG and F18-NaF. The new system is smaller, more power-driven and features enhancements to technologist workflow, according to the Warrendale, Pa.-based business unit of Bayer HealthCare.
The Intego will be on display at the annual meeting of the Society of Nuclear Medicine (SNM), June 4-8, in San Antonio.